MMF-related side effects in patients.
| Group 1, 56% (10/18) | Group 2, 36% (9/26) |
|---|---|
| Before MMF dose reduction, n = 8 | |
| 3 herpes zoster virus infections | 1 chlamydia-related myocarditis |
| 1 salmonella species gastroenteritis | 1 ulcerative gastritis |
| 2 diarrhea that remitted after tapering of MMF | 1 gastrointestinal discomfort that resolved after reducing MMF from 3 to 2 g/day |
| 2 hypercholesterolemia | |
| After MMF dose reduction, n = 2 | 1 alopecia |
| 1 human papilloma virus | 5 hypercholesterolemia |
| 1 Epstein-Barr virus infection |
MMF: mycophenolate mofetil.